Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combined THC and CBD Drops for Treatment of Crohn's Disease, a Phase II Double Blind Placebo Controlled Trial

NCT01826188 is registered in ClinicalTrials.gov with Meir Medical Center as lead sponsor.

NCT NCT01826188
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01826188 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combined THC and CBD Drops for Treatment of Crohn's Disease, a Phase II Double Blind Placebo Controlled Trial
Lead sponsor
Meir Medical Center
Phase
Phase 1/2
Overall status
Completed
Start date
March 31, 2013
Completion date
June 30, 2018
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease